HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.

AbstractPURPOSE:
To describe leflunomide use in the treatment of drug resistant cytomegalovirus retinitis. Leflunomide has been shown to be effective in the treatment of systemic CMV viremia.
METHODS:
Retrospective chart review of patients with CMV retinitis treated with leflunomide.
RESULTS:
Two HIV-negative organ transplant recipients with UL 97 mutation resistant-genotype CMV were identified. Patient 1 developed CMV viremia post-kidney transplant and subsequently bilateral CMV retinitis. Retinitis progressed, despite intravitreal injection of ganciclovir and foscarnet, and IV foscarnet and oral valganciclovir. Retinitis control was achieved with the addition of oral leflunomide. Disease remained inactive for 22 months. Patient 2 developed CMV retinitis after lung transplant. Disease progressed despite intravitreal foscarnet injections and oral valganciclovir. Control of retinitis was achieved with addition of oral leflunomide, allowing cessation of intravitreal therapy. Disease remained inactive until his death.
CONCLUSIONS:
Leflunomide may be considered as a treatment option for resistant CMV retinitis.
AuthorsLana M Rifkin, Caroline L Minkus, Kenneth Pursell, Chaisiri Jumroendararasame, Debra A Goldstein
JournalOcular immunology and inflammation (Ocul Immunol Inflamm) Vol. 25 Issue 1 Pg. 93-96 (Feb 2017) ISSN: 1744-5078 [Electronic] England
PMID26652481 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiviral Agents
  • Immunosuppressive Agents
  • Isoxazoles
  • Leflunomide
Topics
  • Administration, Oral
  • Aged
  • Antiviral Agents (therapeutic use)
  • Cytomegalovirus (genetics)
  • Cytomegalovirus Retinitis (drug therapy)
  • Drug Resistance, Viral
  • Genotype
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Intravitreal Injections
  • Isoxazoles (therapeutic use)
  • Kidney Transplantation
  • Leflunomide
  • Lung Transplantation
  • Male
  • Middle Aged
  • Retrospective Studies
  • Viremia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: